• Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic americanpharmaceuticalreview
    August 14, 2019
    chrödinger announced an expansion of its computational design collaboration with Morphic Therapeutic, a biotechnology company focused on developing a new class of oral small-molecule integrin-targeted therapeutics that Schrödinger co-founded with ...
PharmaSources Customer Service